Arm CEO: AI will cure cancer but chip shortage slowing progress

Rene Haas, CEO of Cambridge-based chip designer Arm Holdings, told the BBC's Big Boss Interview podcast that modelling how a DNA marker is impacted by cancer is currently "too complex" a problem, but that computers are "going to solve it" in the future.

"AI is going to... find a cure for cancer that today you and I, other humans [could] not in our lifetimes. I believe in our lifetime, AI will help cure cancer," Haas said.

Arm designs the central processors used in hundreds of billions of phones, cars, smartwatches and other gadgets worldwide. Earlier this summer, the company's peak share price amid the AI boom made it, in cash terms, the most valuable UK-headquartered company in history.

Haas, who stepped down from the board of British pharmaceutical giant AstraZeneca in April, also predicted that AI would lead to widespread humanoid robots within the next five years. However, he expressed scepticism about the possibility of chips being manufactured in the UK in the future.

"Modelling a cell, modelling a human, modelling how a DNA marker is impacted by cancer - it's too complex a problem, not only for humans today, but the computers that run AI," Haas said. "However, going forward, as we feed more and more of the models into these computers, and the computers get more sophisticated to run the models, they're going to solve it."

Why This Matters

AI-driven medical breakthroughs could transform healthcare, with potential cures for currently intractable diseases such as cancer.
The chip shortage directly impacts the pace of AI development, affecting everything from drug discovery to robotics.
Arm's status as the UK's most valuable tech firm highlights the country's role in the global semiconductor and AI supply chain.

Background

Arm Holdings, headquartered in Cambridge, designs the processor architecture used in the vast majority of mobile devices and a growing number of data centre chips. Its technology is central to the AI boom, as companies like Nvidia rely on Arm-based designs for energy-efficient computing. The global semiconductor shortage has persisted for years, constraining the construction of the data centres needed to train and run large AI models.

Key Perspectives

Rene Haas, Arm CEO: Optimistic that AI will solve problems beyond human capability, including cancer, but realistic about current infrastructure constraints and the difficulty of domestic chip manufacturing. Tech industry analysts: The chip shortage is a bottleneck for AI progress; Arm's low-power designs are critical for scaling AI to edge devices and data centres alike. Critics/Sceptics: Some question whether AI will deliver transformative medical breakthroughs as quickly as predicted, and note that chip shortages could worsen if geopolitical tensions disrupt supply chains.

What to Watch

Progress in building new semiconductor fabrication plants, particularly in the US and Europe, to ease chip supply.
UK government initiatives to boost semiconductor manufacturing and whether Arm can expand its role in AI hardware.
Clinical trial results or research milestones that validate AI's ability to model complex biological systems.

ZOTPAPER